Transcranial magnetic stimulation has become an established option for people whose depression has not responded to medication. The treatment uses magnetic pulses to stimulate regions of the brain involved in mood regulation. Interest has grown as more patients seek alternatives after antidepressants fall short.
Understanding what the research actually shows helps set realistic expectations. TMS is neither a cure-all nor a fringe experiment. The evidence places it as a credible option for a specific group of patients.
What Is Treatment-Resistant Depression?
Treatment-resistant depression generally describes major depression that has not improved after at least two adequate antidepressant trials. The label reflects a real clinical challenge rather than a separate diagnosis. A substantial share of people with depression fall into this category.
Estimates suggest roughly a third of patients do not reach remission with standard medications. For them, additional options matter.
How Does TMS Work?
TMS works by delivering focused magnetic pulses to the dorsolateral prefrontal cortex, an area linked to mood regulation. The pulses induce small electrical currents that influence neural activity. The approach is noninvasive and requires no anesthesia.
Sessions are conducted in an outpatient setting while the patient is awake. A typical course runs five days a week over several weeks. Each session lasts from a few minutes to under an hour depending on the protocol.
What Does the Research Show?
Research on TMS for treatment-resistant depression has reported meaningful response in a notable share of patients. Some studies describe response rates near half and remission in roughly a third, though figures vary across protocols.
Clinics offering deep TMS therapy in St. Louis typically follow protocols studied in clinical trials, where outcomes depend on factors like diagnosis, prior treatment history, and adherence to the full course. Results differ from one person to the next.
The FDA first cleared TMS for major depression in 2008. Subsequent clearances expanded its approved uses. That regulatory history reflects an accumulating evidence base.
What Is Deep TMS?
Deep TMS uses a specialized coil designed to reach broader and deeper cortical regions than standard figure-eight coils. The aim is to engage networks involved in mood more fully. It is one variation within the broader TMS family.
Like other forms, deep TMS is delivered over a structured course. Protocols are based on patterns tested in research.
What Are the Side Effects?
The most common side effects of TMS are mild and localized. Scalp discomfort and headache during or after sessions are the usual complaints.
Serious side effects are rare. The most significant theoretical risk is a seizure, which occurs very infrequently under standard protocols. Screening helps identify people for whom the treatment may not be appropriate.
Who Might Be a Candidate?
Candidates for TMS are typically adults with major depression that has not responded adequately to medication. A clinical evaluation determines suitability. Medical history and certain implants can affect eligibility.
The decision involves weighing prior treatments and individual circumstances. TMS is one option among several for treatment-resistant cases.
How Long Do Results Last?
Research suggests many patients who respond to TMS maintain improvement for months afterward. Durability varies, and some patients benefit from maintenance sessions. Long-term outcomes continue to be studied.
Ongoing care often accompanies TMS regardless of immediate results. Therapy and medication may continue alongside or after a course.
How Does TMS Fit Into Treatment?
TMS usually fits into a broader treatment plan rather than standing alone. It is often considered after medication trials have fallen short. Clinicians integrate it with other supports as appropriate.
Coordination across treatments tends to produce the best results. TMS addresses one dimension of a complex condition.
The evidence positions TMS as a credible option for treatment-resistant depression, with research reporting meaningful response in a substantial share of patients. Outcomes vary, and the treatment works best as part of coordinated care.
For people who have not found relief through medication, the practical takeaway is that further options exist. A clinical evaluation can clarify whether TMS is a reasonable next step.